“…Second, variation in assays used for HIV screening, laboratory capacity, and testing proficiency among the countries might result in an over-or under-estimation of the HIV prevalence in collected units, which cannot be quantified. Finally, estimations of transfusion-associated HIV infections might underestimate the proportion of countries' overall annual HIV incidence attributable to unsafe blood, mainly because current incidence models do not account for test quality or rates of false negativity (9). Stronger donor selection criteria and improved screening technologies have reduced the number of HIV-positive donors being screened for donation and improved detection of HIV infections among donors, respectively (10).…”